Astrana Health, Inc.

ASTH Healthcare Medical Care Facilities

Astrana Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 56.4% from fiscal 2024. In the quarter to June 2026, revenue grew 48.5%, EPS grew 110.5%, free cash flow fell 67.7% and total debt rose 126.4%, each against the same quarter a year earlier. Revenue growth for five consecutive years.

36.81 1.22 −3.21%
Market cap
$1.9B
P/E
44.3×
Fwd P/E
29.7×
Dividend yield
—
F-score
4/9
Altman Z
2.39
Beneish M
−2.19
Dividend safety
50/100
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
55.92 39.55 53.93 149.21

+8 more quarters

P/S ratio
0.59 0.34 0.38 0.48
P/FCF ratio
24.15 7.73 11.65 14.39
P/Operating CF
69.61 17.60 (421.89) 140.16
P/B ratio
2.71 1.47 1.53 1.77
EV/Sales
0.73 0.50 0.57 0.68
EV/EBITDA
16.75 12.02 14.24 19.49
EV/FCF
29.83 11.27 17.48 20.44
Current Ratio
1.23 1.35 1.40 1.40
Net Debt/EBITDA
10.50 12.17 16.95 16.31
Debt/Equity
1.11 1.26 1.31 1.33
Earnings Yield
1.79% 2.53% 1.85% 0.67%
Free Cash Flow Yield
4.14% 12.94% 8.58% 6.95%
Free Cash Flow per Share
0.59 1.31 (0.12) 0.15
Book value per Share
17.12 16.69 16.16 16.03
Free Cash Flow
28.87 64.06 (5.95) 7.40
EV/EBIT
28.03 20.21 23.26 32.57
Other line items

Show all line items

Columns are period end dates